Patient Blood Management (PBM) is an evidence-based bundle of care to optimise medical and surgical patient outcomes by clinically managing and preserving a patient's blood
The International Foundation for Patient Blood Management is committed to ensuring that a patient’s own blood, this unique and vital human resource, is appropriately managed and maintained in health and disease. To this end the Foundation promotes scientifically based medical and surgical Patient Blood Management techniques aimed at conserving a patient’s blood and minimizing or avoiding the need for the transfusion of allogeneic blood components.
The Foundation acknowledges that altruistically donated allogeneic blood, given in trust, is a valuable community resource. However, it is a costly resource with significant potential for adverse clinical outcomes. Accordingly, it should only be used as a therapy with patient consent when there is evidence for potential benefit, there are no alternatives, and the risks are appropriately considered and balanced against the benefits.
The shift away from standard transfusion practice to Patient Blood Management (PBM) is gaining momentum worldwide. The World Health Organisation (WHO) has highlighted the importance of Patient Blood Management and the European Commission has published two guides on Patient Blood Management. In Australia, the National Blood Authority has published Guidelines to implement PBM. However it is a 'paradigm shift' that will take time to finally become the new 'gold standard' of care.
Organizations such as the International Foundation for Patient Blood Management are at the forefront of this shift. Established in 2015 as a not-for-profit Swiss Foundation, the Foundation's aim is to improve patient outcomes by promoting, expanding and improving evidence-based PBM in clinical practice. Driven by the world’s leading PBM experts and grounded in scientific validation and evidence-based practice, the Foundation promotes education and training to enable change.